Frontlight ResearchEarly access
Trial site
Jinzhou Central Hospital
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 34 trials
- Status
- Completed3 trials
- Not yet recruiting3 trials
- Lead sponsor
- Akeso1 trial
- Boehringer Ingelheim1 trial
- Dongzhimen Hospital, Beijing1 trial
- Peking University First Hospital1 trial
- Shenzhen HighTide Biopharmaceutical Ltd.1 trial
- and 1 more
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Completed
Completed
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 12 Nov 2026